Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points.
Maura RossiAlessio GambinoMarco CabrasManuela AlessioVittorio FuscoPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
Keyphrases